Effects of Testosterone on Ventricular Repolarization in Hypogonadic Men

American Journal of Cardiology

Volumn 103, Issue 6, 2009, Pages 887-890

  Charbit, Beny ^a,b   Christin Maître, Sophie ^c   Démolis, Jean Louis ^a,b   Soustre, Elsa ^a,b   Young, Jacques ^d   Funck Brentano, Christian ^a,b  

^a INSERM   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TESTOSTERONE ENANTATE;

ADULT; ARTICLE; CLINICAL ARTICLE; ELECTROCARDIOGRAPHY; HEART REPOLARIZATION; HUMAN; HYPOGONADISM; MALE; PRIORITY JOURNAL; QT INTERVAL; SEX DIFFERENCE; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; ELECTROCARDIOGRAPHY; EXERCISE TEST; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; TESTOSTERONE; VENTRICULAR FUNCTION;

EID: 61349199567     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.11.041     Document Type: Article

References (26)

1. Rautaharju P.M., Zhou S.H., Wong S., Calhoun H.P., Berenson G.S., Prineas R., and Davignon A. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 8 (1992) 690-695
2. Mayuga K.A., Parker M., Sukthanker N.D., Perlowski A., Schwartz J.B., and Kadish A.H. Effects of age and gender on the QT response to exercise. Am J Cardiol 87 (2001) 163-167
3. Makkar R.R., Fromm B.S., Steinman R.T., Meissner M.D., and Lehmann M.H. Female gender as a risk factor for Torsades de Pointes associated with cardiovascular drugs. JAMA 270 (1993) 2590-2597
4. Drici M.D., Burklow T.R., Haridasse V., Glazer R.I., and Woosley R.L. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation 94 (1996) 1471-1474
5. Hulot J.S., Démolis J.L., Rivière R., Strabach S., Christin-Maitre S., and Funck-Brentano C. Influence of endogenous oestrogens on QT interval duration. Eur Heart J 24 (2003) 1663-1667
6. Burke J.H., Ehlert F.A., Kruse J.T., Parker M.A., Goldberger J.J., and Kadish A.H. Gender-specific differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults. Am J Cardiol 79 (1997) 178-181
7. Vrtovec B., Starc V., and Meden-Vrtovec H. The effect of estrogen replacement therapy on ventricular repolarization dynamics in healthy postmenopausal women. J Electrocardiol 34 (2001) 277-283
8. Larsen J.A., Tung R.H., Sadananda R., Goldberger J.J., Horvath G., Parker M.A., and Kadish A.H. Effects of hormone replacement therapy on QT interval. Am J Cardiol 82 (1998) 993-995
9. Liu X.K., Katchman A., Kruse J.T., Parker M.A., Woosley R.L., and Ebert S.N. Gender-specific differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults. Am J Cardiol 79 (1997) 28-36
10. Bidoggia H., Maciel J.P., Capalozza N., Mosca S., Blaksley E.J., Valverde E., Bertran G., Arini P., Biagetti M.O., and Quinteiro R.A. Sex differences on the electrocardiographic pattern of cardiac repolarization: possible role of testosterone. Am Heart J 140 (2000) 678-683
11. Lepeschkin E., and Surawicz B. The measurement of the QT interval of the electrocardiogram. Circulation 6 (1952) 378-388
12. Funck-Brentano C., Kibleur Y., Le Coz F., Poirier J.M., Mallet A., and Jaillon P. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans. Circulation 83 (1991) 536-545
13. Démolis J.L., Martel C., Funck-Brentano C., Sachse A., Weimann H.J., and Jaillon P. Effects of tedisamil, atenolol and their combination on heart and rate-dependent QT interval in healthy volunteers. Br J Clin Pharmacol 44 (1997) 403-409
14. Démolis J.L., Strabach S., Vacheron F., and Funck-Brentano C. Assessment of the effect of a single oral dose of telithromycin on sotalol-induced QT interval prolongation in healthy women. Br J Clin Pharmacol 60 (2005) 120-127
15. Liu X.K., Katchman A., Whitfield B.H., Wan G., Janowski E.M., Woosley R.L., and Ebert S.N. In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits. Cardiovasc Res 57 (2003) 28-36
16. Bai C.X., Kurokawa J., Tamagawa M., Nakaya H., and Furukawa T. Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation 112 (2005) 1701-1710
17. Pham T.V., Sosunov E.A., Gainullin R.Z., Danilo Jr. P., and Rosen M.R. Impact of sex and gonadal steroids on prolongation of ventricular repolarization and arrhythmias induced by I(K)-blocking drugs. Circulation 103 (2001) 2207-2212
18. Benoit S.R., Mendelsohn A.B., Nourjah P., Staffa J.A., and Graham D.J. Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey. Eur J Cardiovasc Prev Rehabil 12 (2005) 363-368
19. Burger H.G. Androgen production in women. Fertil Steril 77 suppl (2002) S3-S5
20. Vermeulen A., Verdonck L., and Kaufman J.M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84 (1999) 3666-3672
21. Kaufman J.M., and Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26 (2005) 833-876
22. Mohr B.A., Guay A.T., O'Donnell A.B., and McKinlay J.B. Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) 62 (2005) 64-73
23. Sohaib S.M., Papacosta O., Morris R.W., Macfarlane P.W., and Whincup P.H. Length of the QT interval: determinants and prognostic implications in a population-based prospective study of older men. J Electrocardiol 41 (2008) 704-710
24. Ebert S.N., Liu X.K., and Woosley R.L. Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence. J Womens Health 7 (1998) 547-557
25. Drici M.D., Knollmann B.C., Wang W.X., and Woosley R.L. Cardiac actions of erythromycin: influence of female sex. JAMA 280 (1998) 1774-1776
26. Shifren J.L., Braunstein G.D., Simon J.A., Casson P.R., Buster J.E., Redmond G.P., Burki R.E., Ginsburg E.S., Rosen R.C., Leiblum S.R., et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343 (2000) 682-688